Detalhe da pesquisa
1.
Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.
Cell Immunol
; 342: 103780, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29571923
2.
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.
Mol Ther
; 22(11): 1923-35, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25200009
3.
Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donors.
J Immunol
; 188(12): 6418-24, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22593612
4.
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Brain
; 135(Pt 2): 483-92, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22240777
5.
A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.
Mol Ther
; 19(11): 2084-91, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21629225
6.
Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.
Sci Rep
; 10(1): 864, 2020 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965041
7.
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation.
J Transl Med
; 7: 10, 2009 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19173717
8.
BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
Cancer Res
; 65(14): 6409-17, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16024645
9.
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Nat Commun
; 8: 16105, 2017 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742067
10.
Similar immune responses and antitumor effects of murine dendritic cells loaded with either exogenous or endogenous-synthesized protein.
Int J Oncol
; 23(6): 1747-53, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14612950
11.
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
Sci Transl Med
; 6(220): 220ra10, 2014 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452262
12.
Polymers for improving the in vivo transduction efficiency of AAV2 vectors.
PLoS One
; 5(12): e15576, 2010 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21203395
13.
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Hum Gene Ther
; 21(6): 704-12, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20095819
14.
Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2.
J Virol
; 81(10): 5385-94, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17314166